scholarly journals Vaccination of stage III/IV melanoma patients with long NY-ESO-1 peptide and CpG-B elicits robust CD8+ and CD4+ T-cell responses with multiple specificities including a novel DR7-restricted epitope

2016 ◽  
Vol 5 (10) ◽  
pp. e1216290 ◽  
Author(s):  
P. Baumgaertner ◽  
C. Costa Nunes ◽  
A. Cachot ◽  
H. Maby-El Hajjami ◽  
L. Cagnon ◽  
...  
Keyword(s):  
T Cell ◽  
T Cell Responses ◽  
Cd4 T Cell ◽  
Stage Iii ◽  
Cell Responses ◽  
Melanoma Patients ◽  
Restricted Epitope

scholarly journals Vaccination with long NY-ESO-1 79-108 peptide and CpG-B leads to robust activation of CD4 and CD8 T cell responses in stage III/IV melanoma patients, and a new HLA-DR7 epitope

2015 ◽  
Vol 3 (Suppl 2) ◽  
pp. P437
Author(s):  
Petra Baumgartner ◽  
Carla Nunes ◽  
Amélie Cachot ◽  
Hélène Hajjami ◽  
Laurène Cagnon ◽  
...  
Keyword(s):  
T Cell ◽  
T Cell Responses ◽  
Cd8 T Cell ◽  
Stage Iii ◽  
Cell Responses ◽  
Melanoma Patients

scholarly journals CD4+ T Cell Responses to SSX-4 in Melanoma Patients

2005 ◽  
Vol 174 (8) ◽  
pp. 5092-5099 ◽  
Author(s):  
Maha Ayyoub ◽  
Andrea Merlo ◽  
Charles S. Hesdorffer ◽  
Donata Rimoldi ◽  
Daniel Speiser ◽  
...  
Keyword(s):  
T Cell ◽  
T Cell Responses ◽  
Cd4 T Cell ◽  
Cell Responses ◽  
Melanoma Patients

scholarly journals Enhancement of Tumor-Reactive Cytotoxic CD4+ T-cell Responses after Ipilimumab Treatment in Four Advanced Melanoma Patients

2013 ◽  
Vol 1 (4) ◽  
pp. 235-244 ◽  
Author(s):  
Shigehisa Kitano ◽  
Takemasa Tsuji ◽  
Caillian Liu ◽  
Daniel Hirschhorn-Cymerman ◽  
Chrisann Kyi ◽  
...  
Keyword(s):  
T Cell ◽  
T Cell Responses ◽  
Advanced Melanoma ◽  
Cd4 T Cell ◽  
Cell Responses ◽  
Melanoma Patients
Sign in / Sign up

Export Citation Format

Share Document